Literature DB >> 2903501

Conserved upstream sequences of human class II major histocompatibility genes enhance expression of class II genes in wild-type but not mutant B-cell lines.

J H Sloan1, J M Boss.   

Abstract

Class II major histocompatibility genes contain a conserved upstream sequence (CUS) that is important in the expression of these genes. This region has been divided into two major elements, the X box and the Y box. The ability of these elements to mediate transcription of a heterologous promoter was assayed upon transfection into a B-cell line (Raji), a class II-specific trans-acting factor-deficient B-cell line (RJ2.2.5 cells), and a T-cell line (Jurkat). The results showed that the X box element was responsible for directing tissue-specific expression when Raji cells were compared to Jurkat cells. The X box could not direct expression of the heterologous promoter in the trans-acting factor-deficient cell line, indicating that the X box is an ultimate target of the missing or defective factor in the RJ2.2.5 cell line. The Y box directed an equal but extremely low level of transcription in this system in both the mutant and wild-type B-cell lines, suggesting that this element is not involved in B-cell expression or as a target of the mutant factor.

Entities:  

Mesh:

Year:  1988        PMID: 2903501      PMCID: PMC282392          DOI: 10.1073/pnas.85.21.8186

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji).

Authors:  M A Epstein; B G Achong; Y M Barr; B Zajac; G Henle; W Henle
Journal:  J Natl Cancer Inst       Date:  1966-10       Impact factor: 13.506

Review 2.  Role of MHC gene products in immune regulation.

Authors:  B Benacerraf
Journal:  Science       Date:  1981-06-12       Impact factor: 47.728

Review 3.  The class II molecules of the human and murine major histocompatibility complex.

Authors:  J F Kaufman; C Auffray; A J Korman; D A Shackelford; J Strominger
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

4.  Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimaeric plasmids.

Authors:  F Lee; R Mulligan; P Berg; G Ringold
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

5.  The murine E alpha immune response gene.

Authors:  D J Mathis; C O Benoist; V E Williams; M R Kanter; H O McDevitt
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

6.  Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon.

Authors:  J S Pober; T Collins; M A Gimbrone; R S Cotran; J D Gitlin; W Fiers; C Clayberger; A M Krensky; S J Burakoff; C S Reiss
Journal:  Nature       Date:  1983 Oct 20-26       Impact factor: 49.962

7.  Complete primary structures of the E beta chain and gene of the mouse major histocompatibility complex.

Authors:  H Saito; R A Maki; L K Clayton; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

8.  Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets.

Authors:  R S Accolla
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

9.  Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines.

Authors:  Z Yang; R S Accolla; D Pious; B J Zegers; J L Strominger
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

10.  Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.

Authors:  S Gillis; J Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  25 in total

1.  Analysis of the mouse Dhfr/Rep-3 major promoter region by using linker-scanning and internal deletion mutations and DNase I footprinting.

Authors:  M L Smith; P J Mitchell; G F Crouse
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Transcription analysis of class II human leukocyte antigen genes from normal and immunodeficient B lymphocytes, using polymerase chain reaction.

Authors:  M Bull; A van Hoef; J Gorski
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

Review 3.  Transcriptional regulation of HLA class-II genes.

Authors:  B M Peterlin; G Andersson; E Lötscher; S Tsang
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

4.  B-cell factor 1 is required for optimal expression of the DRA promoter in B cells.

Authors:  C F Voliva; A Aronheim; M D Walker; B M Peterlin
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

5.  DNA binding properties of YB-1 and dbpA: binding to double-stranded, single-stranded, and abasic site containing DNAs.

Authors:  S L Hasegawa; P W Doetsch; K K Hamilton; A M Martin; S A Okenquist; J Lenz; J M Boss
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

6.  Regulatory factor-X binding to mutant HLA-DRA promoter sequences.

Authors:  S L Hasegawa; J H Sloan; W Reith; B Mach; J M Boss
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

7.  Effect of the AIR-1 locus on the activation of an enhancerless HLA-DQA1 promoter.

Authors:  M N Ombra; G Del Pozzo; C Perfetto; A Maffei; J Guardiola
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

8.  Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors.

Authors:  S Y Tsang; M Nakanishi; B M Peterlin
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

9.  The MHC class II E beta promoter: a complex arrangement of positive and negative elements determines B cell and interferon-gamma (IFN-gamma) regulated expression.

Authors:  D Thanos; M Gregoriou; D Stravopodis; K Liapaki; T Makatounakis; J Papamatheakis
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

10.  The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

Authors:  J A Brown; E M Rogers; J M Boss
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.